The Use of Continuous Intrathecal Infusion of Octreotide in Patients with Chronic Pain of Noncancer Origin: An Evaluation of Side-effects and Toxicity in a Prospective Double-blind Fashion.
about
Current developments in intraspinal agents for cancer and noncancer pain.Future directions for intrathecal pain management: a review and update from the interdisciplinary polyanalgesic consensus conference 2007.The use of continuous intrathecal infusion of octreotide in patients with chronic pain of noncancer origin: an evaluation of efficacy in a prospective double-blind fashion.
P2860
The Use of Continuous Intrathecal Infusion of Octreotide in Patients with Chronic Pain of Noncancer Origin: An Evaluation of Side-effects and Toxicity in a Prospective Double-blind Fashion.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The Use of Continuous Intrathe ...... spective Double-blind Fashion.
@en
The Use of Continuous Intrathe ...... spective Double-blind Fashion.
@nl
type
label
The Use of Continuous Intrathe ...... spective Double-blind Fashion.
@en
The Use of Continuous Intrathe ...... spective Double-blind Fashion.
@nl
prefLabel
The Use of Continuous Intrathe ...... spective Double-blind Fashion.
@en
The Use of Continuous Intrathe ...... spective Double-blind Fashion.
@nl
P2093
P2860
P1433
P1476
The Use of Continuous Intrathe ...... spective Double-blind Fashion.
@en
P2093
C Douglas Stewart
Christopher K Kim
Matt Norris
Richard G Bowman
Richard Penn
Timothy R Deer
Tina Garten
Yusuf Khan
P2860
P304
P356
10.1111/J.1525-1403.2005.05235.X
P577
2005-07-01T00:00:00Z